title: Recent advances in the management of chronic heart failure.
abstract: BACKGROUND
  The management of chronic heart failure (CHF) has undergone a revolution in the past decade, highlighted by dramatic turnarounds in opinion, renewed focus on 'traditional' therapies and the emergence of novel diagnostic and treatment options.
  
  
  OBJECTIVE
  Based on review of the current evidence, this article aims to provide an update of the issues pertaining to the diagnosis and treatment of CHF.
  
  
  CONCLUSIONS
  Underlying this revolution on the management of CHF have been novel insights into the pathophysiology of CHF. Promising findings from recent clinical trials will also be examined in this article.
authors.affiliation: Clinical Pharmacology Unit, Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Melbourne, Vic 3004. henry.krum@med.monash.edu.au
authors.forename: Henry
authors.initials: H
authors.lastname: Krum
authors.forename: Danny
authors.initials: D
authors.lastname: Liew
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D018754:Ventricular Dysfunction / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors